Journal of Clinical Pediatrics >
Analysis of clinical and genetic detection results of 3 children with FOXG1-related syndrome
Received date: 2023-11-07
Online published: 2024-09-04
Objective To investigate the clinical phenotypic and genotypic features of FOXG1-related syndrome. Methods The clinical data and genetic test results of 3 children with FOXG1-related syndrome treated in our hospital from January 2018 to January 2022 were analyzed retrospectively. Results Three children with FOXG1-related syndrome were included, all male, with postnatal onset. All the patients had early-onset dyskinesia, global developmental delay and microcephaly. Whole exome sequencing showed that all 3 patients had the pathogenic variation of FOXG1 gene. Brain magnetic resonance imaging (MRI) was characterized by hypoplasia of the frontal cortex and/or corpus callosum or delayed myelination. Case 1 had a frameshift mutation of c.256dupC (p.Gln86Profs*35) at the N-terminal domain site in the FOXG1 gene, and case 2 had a nonsense mutation of c.595G>T (p.Glu199*) in the fork-head binding domain of FOXG1 gene. A nonsense of c.1178C>A (p.S393*) was found in the JARID1B binding domain of FOXG1 gene in case 3. Case 3 had a milder clinical phenotype and brain abnormalities than the other 2 patients. The variations of cases 2 and 3 had not been previously reported in the literature, which expanded the gene spectrum of the disease. Conclusions FOXG1 variation should be considered for individuals with early-onset dyskinesia, developmental delay, microcephaly and characteristic brain imaging lesions.
Key words: FOXG1gene; movement disorder; developmental delay; microcephaly
Dianrong SUN , Yanyan WANG , Jiashan LI , Leihong ZHANG , Mei HOU . Analysis of clinical and genetic detection results of 3 children with FOXG1-related syndrome[J]. Journal of Clinical Pediatrics, 2024 , 42(9) : 805 -810 . DOI: 10.12372/jcp.2024.23e1074
[1] | Shoichet SA, Kunde SA, Viertel P, et al. Haploinsufficiency of novel FOXG1B variants in a patient with severe mental retardation, brain malformations and microcephaly[J]. Hum Genet, 2005, 117(6): 536-544. |
[2] | Mencarelli MA, Kleefstra T, Katzaki E, et al. 14q12 Microdeletion syndrome and congenital variant of Rett syndrome[J]. Eur J Med Genet, 2009, 52(2-3): 148-152. |
[3] | Lee-Chin Wong, Yen-Tzu Wu, Chia-Jui Hsu, et al. Cognition and evolution of movement disorders of FOXG1-related syndrome[J]. Front Neurol, 2019, 10: 641. |
[4] | Akol I, Gather F, Vogel T. Paving Therapeutic avenues for FOXG1 syndrome: untangling genotypes and phenotypes from a molecular perspective[J]. Int J Mol Sci, 2022, 23(2): 954. |
[5] | Wong LC, Huang CH, Chou WY, et al. The clinical and sleep manifestations in children with FOXG1 syndrome[J]. Autism Res, 2023, 16(5): 953-966. |
[6] | Kortüm F, Das S, Flindt M, et al. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis[J]. J Med Genet, 2011, 48(6): 396-406. |
[7] | Mitter D, Pringsheim M, Kaulisch M, et al. FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants[J]. Genet Med, 2018, 20(1): 98-108. |
[8] | Bjerregaard VA, Levy AM, Batz MS, et al. Involvement of mitochondrial dysfunction in FOXG1 syndrome[J]. Genes (Basel), 2023, 14(2): 246. |
[9] | Dai S, Li J, Zhang H, et al. Structural basis for DNA recognition by FOXG1 and the characterization of disease-causing FOXG1 Mutations[J]. J Mol Biol, 2020, 432(23): 6146-6156. |
[10] | Wilpert NM, Marguet F, Maillard C, et al. Human neuropathology confirms projection neuron and interneuron defects and delayed oligodendrocyte production and maturation in FOXG1 syndrome[J]. Eur J Med Genet, 2021, 64(9): 104282. |
[11] | Yu B, Liu J, Su M, et al. Disruption of Foxg1 impairs neural plasticity leading to social and cognitive behavioral defects[J]. Mol Brain, 2019, 12(1): 63. |
[12] | Brimble E, Reyes KG, Kuhathaas K, et al. Expanding genotype-phenotype correlations in FOXG1 syndrome: results from a patient registry[J]. Orphanet J Rare Dis, 2023, 18(1): 149. |
[13] | Caporali C, Signorini S, De Giorgis V, et al. Early-onset movement disorder as diagnostic marker in genetic syndromes: three cases of FOXG1-related syndrome[J]. Eur J Paediatr Neurol, 2018, 22(2): 336-339. |
[14] | Wong LC, Singh S, Wang HP, et al. FOXG1-related syndrome: from clinical to molecular genetics and pathogenic mechanisms[J]. Int J Mol Sci, 2019, 20(17): 4176. |
[15] | Vegas N, Cavallin M, Maillard C, et al. Delineating FOXG1 syndrome: from congenital microcephaly to hyperkinetic encephalopathy[J]. Neurol Genet, 2018, 4(6): e281. |
[16] | Iwayama H, Tanaka T, Aoyama K, et al. Regional difference in myelination in monocarboxylate transporter 8 deficiency: case reports and literature review of cases in Japan[J]. Front Neurol, 2021, 12: 657820. |
[17] | Sakata Y, Sano K, Aoki S, et al. Neurochemistry evaluated by MR spectroscopy in a patient with SPTAN1-related developmental and epileptic encephalopathy[J]. Brain Dev, 2022, 44(6): 415-420. |
[18] | Hou PS, hAilín Dó, Vogel T, et al. Transcription and beyond: delineating FOXG1 function in cortical development and disorders[J]. Front Cell Neurosci, 2020, 14: 35. |
[19] | Lu G, Zhang Y, Xia H, et al. Identification of a de novo mutation of the FOXG1 gene and comprehensive analysis for molecular factors in Chinese FOXG1-related encephalopathies[J]. Front Mol Neurosci, 2022, 15: 1039990. |
/
〈 |
|
〉 |